Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e6af933919fad4bb75411810e6c3c25 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
filingDate |
2019-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b8b1932ce607918126e1b94e6ab031e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03aa06208430cbecaac0ea9b5331187e |
publicationDate |
2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110452300-A |
titleOfInvention |
For detecting and/or treating the antibody of the consecutive complications of non-therapeutic advance in NAFLD/NASH and liver |
abstract |
This disclosure relates to further relate to the anti-CHI3L1 antibody for detecting and/or treating the consecutive complications of non-therapeutic advance in NAFLD/NASH and liver in conjunction with the antibody and application thereof of human chitinase -3- sample albumen 1 (CHI3L1).At several aspects, the antibody can be used for detecting and/or treating in nonalcoholic fatty liver disease (NAFLD) or non-alcoholic fatty liver disease (NASH) and main body liver in main body in the composition and method of consecutive complications, such as cirrhosis and the hepatocellular carcinoma of non-therapeutic advance. |
priorityDate |
2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |